- Home
- / Fibrocell Science
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Fibrocell Science financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 153.0K | 200.0K | 180.0K | 492.0K | 355.0K | ||
| Revenue growth, % | -10.0% | 173.3% | -27.8% | ||||
| Cost of goods sold | 8.4M | 8.1M | 2.3M | 722.0K | 697.0K | ||
| Gross profit | (8.2M) | (7.9M) | (2.1M) | (230.0K) | (342.0K) | ||
| Gross profit margin, % | -5360.8% | -3926.0% | -1184.4% | -46.7% | -96.3% | ||
| General and administrative expense | 12.2M | 10.1M | 11.6M | 11.3M | 9.8M | 6.7M | 6.4M |
| Operating expense total | 21.2M | 22.7M | 27.8M | 37.2M | 26.1M | 19.0M | 12.4M |
| Depreciation and amortization | 200.0K | ||||||
| EBIT | (29.4M) | (30.5M) | (30.0M) | (37.4M) | (26.5M) | (19.0M) | (12.4M) |
| EBIT margin, % | -19209.2% | -15251.5% | -16641.1% | -7603.0% | -7458.9% | ||
| Interest income | 368.0K | 17.0K | |||||
| Interest expense | 1.0M | 6.0K | 8.0K | 56.0K | 300.0K | ||
| Pre tax profit | (26.1M) | (30.6M) | (25.6M) | (34.5M) | (15.3M) | (16.2M) | (10.3M) |
| Income tax expense | (2.5M) | ||||||
| Net Income | (23.2M) | (30.6M) | (25.6M) | (34.5M) | (15.3M) | (16.2M) | (10.3M) |